Anterix Inc. $ATEX Stake Lessened by Strs Ohio

Strs Ohio lessened its holdings in Anterix Inc. (NASDAQ:ATEXFree Report) by 40.8% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 15,700 shares of the company’s stock after selling 10,800 shares during the period. Strs Ohio’s holdings in Anterix were worth $600,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of ATEX. Charles Schwab Investment Management Inc. lifted its stake in Anterix by 0.4% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 138,677 shares of the company’s stock worth $3,027,000 after acquiring an additional 599 shares in the last quarter. Russell Investments Group Ltd. boosted its stake in shares of Anterix by 12.4% during the 2nd quarter. Russell Investments Group Ltd. now owns 5,760 shares of the company’s stock valued at $148,000 after buying an additional 637 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its stake in shares of Anterix by 17.0% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 7,084 shares of the company’s stock valued at $182,000 after buying an additional 1,029 shares during the period. Tower Research Capital LLC TRC grew its holdings in shares of Anterix by 299.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 1,645 shares of the company’s stock valued at $42,000 after acquiring an additional 1,233 shares in the last quarter. Finally, BNP Paribas Financial Markets grew its holdings in shares of Anterix by 119.3% during the 2nd quarter. BNP Paribas Financial Markets now owns 2,404 shares of the company’s stock valued at $62,000 after acquiring an additional 1,308 shares in the last quarter. Hedge funds and other institutional investors own 87.67% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Wall Street Zen upgraded Anterix from a “sell” rating to a “hold” rating in a report on Saturday, June 27th. B. Riley Financial downgraded Anterix from a “buy” rating to a “neutral” rating and boosted their target price for the company from $44.00 to $69.00 in a research note on Thursday, June 4th. Finally, Weiss Ratings raised Anterix from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 26th. One investment analyst has rated the stock with a Buy rating and three have assigned a Hold rating to the company. Based on data from MarketBeat.com, Anterix has a consensus rating of “Hold” and an average target price of $59.50.

Get Our Latest Research Report on ATEX

Anterix Trading Up 1.8%

Anterix stock opened at $106.86 on Friday. The company has a market capitalization of $2.08 billion, a P/E ratio of 22.08 and a beta of 0.83. The firm’s fifty day simple moving average is $72.60 and its 200-day simple moving average is $46.78. Anterix Inc. has a 1-year low of $17.58 and a 1-year high of $111.90.

Insider Activity

In other Anterix news, CFO Elena Marquez sold 4,291 shares of the business’s stock in a transaction dated Wednesday, June 17th. The stock was sold at an average price of $79.50, for a total value of $341,134.50. Following the completion of the sale, the chief financial officer owned 18,387 shares of the company’s stock, valued at $1,461,766.50. The trade was a 18.92% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Mark Fleischhauer sold 3,500 shares of the company’s stock in a transaction dated Monday, June 15th. The stock was sold at an average price of $79.83, for a total value of $279,405.00. Following the sale, the director owned 12,769 shares of the company’s stock, valued at approximately $1,019,349.27. This trade represents a 21.51% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 124,109 shares of company stock valued at $10,174,158. Corporate insiders own 40.05% of the company’s stock.

About Anterix

(Free Report)

Anterix, Inc is a specialized telecommunications company focused on delivering private broadband networks for utilities and other critical infrastructure industries. The company owns and operates dedicated 900 MHz spectrum that enables reliable, secure and high-performance wireless communications to support grid modernization, smart metering, distribution automation and other mission-critical applications. By leveraging this spectrum, Anterix helps electric, water and gas utilities deploy advanced communications capabilities to enhance operational efficiency and resiliency.

At the core of Anterix’s offering is its licensed 900 MHz spectrum, which provides superior propagation characteristics compared with unlicensed options and allows for cost-effective coverage over expansive service territories.

Recommended Stories

Want to see what other hedge funds are holding ATEX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anterix Inc. (NASDAQ:ATEXFree Report).

Institutional Ownership by Quarter for Anterix (NASDAQ:ATEX)

Receive News & Ratings for Anterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anterix and related companies with MarketBeat.com's FREE daily email newsletter.